Related Experiment Video
Updated: Jul 9, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
The increasing prevalence of hepatitis delta virus (HDV) infection in South London
Timothy J S Cross1, Paolo Rizzi, Mary Horner
1Institute of Liver Studies, King's College Hospital, Denmark Hill, London, UK.
Insights
Hepatitis delta virus (HDV) co-infection is more common than previously thought in the UK, particularly in South London. Testing HBV patients for HDV is crucial due to increased morbidity associated with co-infection.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis delta virus (HDV) infection was historically considered rare in the UK, primarily affecting intravenous drug users.
- Chronic hepatitis B (HBV) is a significant global health concern, and understanding co-infection patterns is vital for patient management.
Purpose of the Study:
- To determine the current prevalence of HDV co-infection among adult patients with chronic HBV in South London.
- To investigate transmission routes, demographic factors, and clinical outcomes associated with HDV/HBV co-infection.
Main Methods:
- Retrospective analysis of 962 adult patients with chronic HBV infection referred to King's College Hospital from 2000 to 2006.
- Assessment of HDV antibody status, demographic data, and potential transmission routes (including intravenous drug use and intra-familial transmission).
- Comparison of clinical characteristics, including hepatitis C co-infection, cirrhosis, and hepatocellular carcinoma risk, between HBV mono-infected and HBV/HDV co-infected patients.
Main Results:
- HDV antibody prevalence was 8.5% (7.1% excluding non-UK residents).
- Most HDV-infected patients were from regions where HDV is endemic; intra-familial transmission and intravenous drug use were common routes.
- HDV/HBV co-infected patients showed higher rates of hepatitis C co-infection and cirrhosis compared to HBV mono-infected patients, but similar hepatocellular carcinoma risk.
Conclusions:
- HDV co-infection demonstrates a higher prevalence in South London than historically reported.
- HDV co-infection is associated with increased morbidity, including higher rates of cirrhosis.
- Routine testing for HDV infection in HBV patients is recommended to identify co-infected individuals and manage associated risks effectively.
Abstract:
On the basis of historical studies, hepatitis delta virus (HDV) infection is considered uncommon in the United Kingdom (UK) and mainly confined to intravenous drug users. In order to assess the current prevalence of HDV co-infection in patients with chronic hepatitis B (HBV), a retrospective analysis was performed of 962 consecutive HBV-infected adult patients referred to King's College Hospital between January 1st 2000 and March 31st 2006. The 82 subjects positive for HDV antibody (8.5%) had a similar age to those without HDV (median 36 years, interquartile range 30-47, vs. 35 years, 29-43). Excluding non-UK residents, the prevalence of HDV Antibody was 7.1%. Most HDV-infected subjects were born in regions where HDV is endemic, for example, Southern or Eastern Europe (28.1%), Africa (26.8%) or Middle-East (7.3%). Forty one (50%) were considered to have acquired HDV infection via intra-familial transmission but intravenous drug use was still a common route of transmission (24.4%). Comparing HBV/HDV co-infected to HBV mono-infected patients, a higher proportion were hepatitis C antibody positive (25.6% versus 3.8%; odds ratio 8.89, 95% confidence interval 4.4-17.9; P < 0.00001) and more had cirrhosis (26.8% vs. 12.9%; odds ratio 2.64, 95% confidence interval 1.55-4.49; P < 0.0001) but, despite this, the risk of hepatocellular carcinoma was similar (odds ratio 1.34, 95% confidence interval 0.62-2.91). Although HDV infection is reportedly declining in some endemic regions, our data demonstrate a high prevalence in South London. HDV co-infection is associated with increased morbidity and patients with HBV should be tested for HDV infection.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Yellow Fever
Genital Herpes
Hemodialysis II: Procedure and Complications